Breaking News Instant updates and real-time market news.

SEDG

SolarEdge

$43.91

-0.65 (-1.46%)

07:46
05/07/19
05/07
07:46
05/07/19
07:46

SolarEdge price target raised to $49 from $43 at Credit Suisse

Credit Suisse analyst Maheep Mandloi raised his price target for SolarEdge to $49 from $43 due to shipment growth. The analyst reiterates a Neutral rating on the shares as he awaits company growth/capex guidance on non-solar businesses, likely by the second half of the year.

  • 15

    May

  • 05

    Jun

SEDG SolarEdge
$43.91

-0.65 (-1.46%)

03/25/19
FBCO
03/25/19
INITIATION
Target $43
FBCO
Neutral
SolarEdge initiated with a Neutral at Credit Suisse
Credit Suisse analyst Maheep Mandloi started coverage of SolarEdge with a Neutral rating and a $43 price target. The analyst notes that the company is an industry leader with a strong balance sheet, 35%-plus gross margins in 2017/18, and the highest penetration in residential and commercial solar due to proprietary solar optimizer and inverter technology, with 50% of the U.S. residential market share. However, three recent acquisitions that could potentially help diversify out of the solar industry are not EPS accretive before 2021 and will be a drag on gross margins and capex requirements, he argues.
05/07/19
JMPS
05/07/19
UPGRADE
JMPS
Outperform
SolarEdge upgraded to Outperform from Market Perform at JMP Securities
05/07/19
JPMS
05/07/19
NO CHANGE
Target $63
JPMS
Overweight
SolarEdge price target raised to $63 from $53 at JPMorgan
JPMorgan analyst Mark Strouse raised his price target for SolarEdge Technologies to $63 from $53 citing the company's "solid" Q1 results and guidance. Industry dynamics remain favorable, with growth driven primarily by Europe during the first half of 2019 and expected by the U.S. during the second half of the year, Strouse tells investors in a post-earnings research note. He expects the stock to react favorably to the print and reiterates an Overweight rating on SolarEdge.
05/07/19
JMPS
05/07/19
UPGRADE
Target $60
JMPS
Outperform
SolarEdge upgraded to Outperform on market share gains at JMP Securities
As previously reported, JMP Securities analyst Joseph Osha upgraded SolarEdge to Outperform from Market Perform, stating that he knew the company had been taking share from European competitors, but he had underestimated how significantly share gains could contribute to revenue growth. While he said he is still not a fan of the company's diversification strategy, Osha said he was wrong to focus there at the expense of the company's core inverter business, which keeps performing extremely well. The analyst, who concluded that SolarEdge's core business is "too strong to ignore," set a $60 price target on the shares.

TODAY'S FREE FLY STORIES

HALO

Halozyme

$15.60

0.385 (2.53%)

05:25
05/22/19
05/22
05:25
05/22/19
05:25
Hot Stocks
Halozyme says argenx selected 2nd target under collaboration, license agreement »

Halozyme Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

  • 31

    May

LM

Legg Mason

$36.89

1.21 (3.39%)

05:24
05/22/19
05/22
05:24
05/22/19
05:24
Upgrade
Legg Mason rating change  »

Legg Mason upgraded to In…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SE

Sea Limited

$25.38

-0.42 (-1.63%)

05:16
05/22/19
05/22
05:16
05/22/19
05:16
Recommendations
Sea Limited analyst commentary  »

Sea Limited price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABMD

Abiomed

$260.47

7.89 (3.12%)

05:13
05/22/19
05/22
05:13
05/22/19
05:13
Recommendations
Abiomed analyst commentary  »

Abiomed 20% selloff this…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 13

    Nov

ABMD

Abiomed

$260.47

7.89 (3.12%)

05:10
05/22/19
05/22
05:10
05/22/19
05:10
Hot Stocks
Abiomed says FDA confirmed Impella RP heart pump is 'safe and effective' »

Abiomed yesterday …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 13

    Nov

ABMD

Abiomed

$260.47

7.89 (3.12%)

05:08
05/22/19
05/22
05:08
05/22/19
05:08
Hot Stocks
FDA says benefits of Impella RP system continue to outweigh risks »

The FDA told doctors in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 13

    Nov

FLIR

Flir Systems

$49.66

0.65 (1.33%)

05:02
05/22/19
05/22
05:02
05/22/19
05:02
Upgrade
Flir Systems rating change  »

Flir Systems upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 27

    Jun

TMDI

Titan Medical

$2.70

0.2 (8.00%)

04:59
05/22/19
05/22
04:59
05/22/19
04:59
Initiation
Titan Medical initiated  »

Titan Medical initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRXC

TransEnterix

$1.27

-0.03 (-2.32%)

04:57
05/22/19
05/22
04:57
05/22/19
04:57
Initiation
TransEnterix initiated  »

TransEnterix initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:55
05/22/19
05/22
04:55
05/22/19
04:55
General news
Breaking General news story  »

Week of 5/17 MBA Mortgage…

PFG

Principal Financial

$55.31

0.41 (0.75%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
Principal Financial Group participates in a conference call with JPMorgan »

Life Insurance Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 11

    Jun

  • 26

    Jul

STML

Stemline

$15.07

0.71 (4.94%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
Stemline management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 31

    May

ARKAY

Arkema

$0.00

(0.00%)

, AVT

Avnet

$43.94

0.84 (1.95%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
Lightfair International to hold a conference »

Lightfair 2019…

ARKAY

Arkema

$0.00

(0.00%)

AVT

Avnet

$43.94

0.84 (1.95%)

CREE

Cree

$58.84

1.41 (2.46%)

ETN

Eaton

$79.88

1.39 (1.77%)

IKTSY

Intertek

$0.00

(0.00%)

ITRI

Itron

$57.78

1.21 (2.14%)

ORCL

Oracle

$54.18

0.54 (1.01%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 04

    Jun

  • 10

    Jun

  • 20

    Aug

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
Credit Suisse U.S. strategist team to hold an analyst/industry conference call »

The U.S. Sector…

MED

Medifast

$146.66

1.35 (0.93%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
Medifast management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 12

    Jun

EXTR

Extreme Networks

$6.15

0.11 (1.82%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
JPMorgan telecom/IT hardware analyst to hold an analyst/industry conference call »

Telecom & IT Hardware…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 28

    May

  • 30

    May

BANR

Banner Corp.

$53.76

-0.04 (-0.07%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
Banner Corp. management to meet with Sandler ONeill »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 04

    Jun

CHD

Church & Dwight

$73.99

-0.02 (-0.03%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
Church & Dwight management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

MSM

MSC Industrial

$75.80

0.57 (0.76%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
MSC Industrial management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

  • 24

    May

  • 05

    Jun

  • 13

    Nov

KLIC

Kulicke & Soffa

$19.35

0.19 (0.99%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
Kulicke & Soffa management to meet with Craig-Hallum »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

CINF

Cincinnati Financial

$99.25

1.07 (1.09%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
Cincinnati Financial management to meet with MKM Partners »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

JAZZ

Jazz Pharmaceuticals

$139.92

1.49 (1.08%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
Jazz Pharmaceuticals management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

  • 31

    May

  • 05

    Jun

  • 23

    Jun

HALO

Halozyme

$15.60

0.385 (2.53%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
Halozyme management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

  • 31

    May

DENN

Denny's

$19.62

-0.03 (-0.15%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
Denny's management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 18

    Jun

  • 13

    Nov

STAY

Extended Stay America

$17.92

0.24 (1.36%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
Extended Stay America management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 30

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.